A ctDNA-guided approach can help identify when patients with HR-positive advanced breast cancer are developing an ESR1 ...

Opioid overdoses are a major public health issue in the U.S., killing tens of thousands of people every year. The medicine ...

Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.

Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

New research published in Allergy indicates that certain environmental exposures may affect a child's risk of developing ...

Lung cancer is the malignant tumor with the highest incidence and mortality rate in the world. With the in-depth research of ...

Switching to camizestrant, a next-generation oral SERD, significantly prolongs progression-free survival and maintains ...

Relacorilant combined with nab-paclitaxel (Abraxane) significantly improved progression-free and overall survival in patients with platinum-resistant ovarian cancer in the phase 3 ROSELLA trial, ...

CBD Life Sciences Inc. (CBDL) has entered the $2.8 billion global suppository market with the launch of its new line of ...

Kisqali plus aromatase inhibitor improved outcomes across age and menopausal status in early hormone receptor–positive, ...

A groundbreaking study has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161 ...